Division of Nephrology and Hypertension, Department of Internal Medicine, University of Utah Health, Salt Lake City, Utah, USA.
Physiol Rep. 2024 Nov;12(21):e70107. doi: 10.14814/phy2.70107.
Obesity paradox refers to the clinical observation that when acute cardiovascular decompensation occurs, patients with obesity may have a survival benefit. This apparently runs counter to the epidemiology of obesity, which may increase the risk for non-communicable diseases (NCDs). The scientific community is split on obesity paradox, with some supporting it, while others call it BMI paradox. This review: (a) defines the obesity paradox, and its proposed role in overall mortality in NCDs; (b) delineates evidence for and against obesity paradox; (c) presents the importance of using different indices of body mass to assess the risk in NCDs; (d) examines the role of metabolically healthy obesity in obesity paradox, and emerging importance of cardio-respiratory fitness (CRF) as an independent predictor of CVD risk and all-cause mortality in patients with/without obesity. Evidence suggests that the development of obesity and insulin resistance are influenced by genetic (or ethnic) make up and dietary habits (culture) of the individuals. Hence, this review presents lean diabetes, which has higher total CVD and non-CVD mortality as compared to diabetics with obesity and the possibility of maternal factors programming cardiometabolic risk during fetal development, which may lead to a paradigm shift in our understanding of obesity.
肥胖悖论是指临床上观察到的一种现象,即在急性心血管失代偿发生时,肥胖患者可能具有生存获益。这显然与肥胖的流行病学相悖,因为肥胖可能会增加非传染性疾病(NCD)的风险。科学界对肥胖悖论存在分歧,一些人支持它,而另一些人则称之为 BMI 悖论。本综述:(a) 定义了肥胖悖论及其在 NCD 总体死亡率中的作用;(b) 阐述了肥胖悖论的证据;(c) 提出了使用不同的体重指数指标来评估 NCD 风险的重要性;(d) 研究了代谢健康型肥胖在肥胖悖论中的作用,以及心肺适能(CRF)作为肥胖和非肥胖患者心血管疾病风险和全因死亡率的独立预测因素的新兴重要性。有证据表明,肥胖和胰岛素抵抗的发展受到个体遗传(或种族)构成和饮食习惯(文化)的影响。因此,本综述提出了瘦型糖尿病,与肥胖糖尿病患者相比,瘦型糖尿病患者的总心血管疾病和非心血管疾病死亡率更高,并且在胎儿发育过程中,母体因素可能会对心脏代谢风险进行编程,这可能会导致我们对肥胖的理解发生范式转变。